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Background and purpose: Our aim was to investigate whether pulsatile tinni-
tus (PT) in cervical artery dissection (CeAD) has prognostic signiﬁcance.
Methods: All CeAD patients from the CADISP (Cervical Artery Dissection
and Ischemic Stroke Patients) study with documentation of PT were analysed.
The presence of PT was systematically assessed using a standardized question-
naire. Stroke severity at admission was deﬁned according to the National
Institutes of Health Stroke Scale (NIHSS). Excellent outcome after 3 months
was deﬁned as a modiﬁed Rankin Scale of 0–1.
Results: Sixty-three of 778 patients (8.1%) reported PT. PT+ patients pre-
sented less often with ischaemic stroke (41.3% vs. 63.9%, P < 0.001), more
often with dissection in the internal carotid artery (85.7% vs. 64.2%,
P = 0.001), less often with vessel occlusion (19.0% vs. 34.1%, P = 0.017) and
more often with excellent outcome at 3 months (92.1% vs. 75.4%, P = 0.002).
Logistic regression analysis identiﬁed PT as an independent predictor of excel-
lent outcome after 3 months [odds ratio (OR) 3.96, 95% conﬁdence interval
(CI) 1.22–12.87] adjusted to signiﬁcant outcome predictors NIHSS on admis-
sion (OR 0.82, 95% CI 0.79–0.86), Horner syndrome (OR 1.95, 95% CI 1.16–
3.29) and vessel occlusion (OR 0.62, 95% CI 0.40–0.94) and to non-signiﬁcant
predictors age, sex, pain and location of CeAD.
Conclusion: The presence of PT in CeAD is associated with a benign clinical
course and predicts a favourable outcome.
Introduction
Cervical artery dissection (CeAD) is a major cause of
stroke in young and middle-aged patients, responsible
for up to 25% of ischaemic strokes. Besides stroke,
CeAD presents with local signs that might occur
solely or in addition to stroke symptoms. Local signs
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include headache, neck pain, Horner syndrome, cra-
nial nerve palsy, cervical-root injury and pulsatile tin-
nitus (PT)[1–3]. PT has been observed in about 5%–
15% of CeAD patients, perhaps favouring female sex
[4–6]. Dissections in the carotid system are about
three times more often associated with PT than dissec-
tions in the vertebral artery system [4]. Diﬀerent
causes can lead to blood ﬂow accelerations and local
turbulence that may result in the perception of PT.
The most probable reason for PT upon CeAD is
higher grade stenosis of the aﬀected artery [7,8]. Here,
patients from the CADISP (Cervical Artery Dissection
and Ischemic Stroke Patients) study were analysed to
investigate whether PT has prognostic signiﬁcance in
CeAD patients.
Methods
The CADISP consortium enrolled 983 CeAD patients
in 18 neurological centres in eight countries, both
prospectively and retrospectively (for more details see
[9,10]). At study entry, detailed signs and symptoms
of each participant were recorded using a standardized
questionnaire [10]. This questionnaire included the
variable ‘presence or absence of PT’, which was used
for the current study. PT was deﬁned as the experi-
ence of perceiving sounds without any known audible
external sound, coinciding with the patient’s heartbeat
lasting for more than 5 min [11,12]. Stroke severity on
admission was assessed with the National Institutes of
Health Stroke Scale (NIHSS). For patients without
ischaemia a dummy value of NIHSS = 0 on admis-
sion was set, as well as for patients without stroke but
with transient ischaemic attack with missing NIHSS
value. Outcome at 3 months was deﬁned as excellent
if modiﬁed Rankin Scale (mRS) was 0–1. Vessel
occlusion was detected via contrast enhanced magnetic
resonance angiography, computed tomography
angiography or ultrasound or using a combination of
them. The parameter pain included both neck pain
and headache. In the current study patients with
reported presence or absence of PT and with docu-
mentation of stroke severity on admission and func-
tional outcome at 3 months were included. One
patient with dissection of the common carotid artery
was excluded.
Statistical analysis
PT+ patients were compared with PT patients. Nor-
mally distributed data are presented as mean and stan-
dard deviation (SD), non-normally distributed data as
median and range. For categorical variables, counts
and percentages are given. Data were compared with
Student’s t test, the MannWhitney U test or the
Fisher exact test where appropriate. Logistic regression
analysis was used to analyse the association between
PT and outcome after adjustment for age, sex, NIHSS,
Horner syndrome, pain, location of the dissection and
vessel occlusion. Because NIHSS and stroke both
reﬂect ischaemic infarction and both are signiﬁcantly
diﬀerent according to PT, only NIHSS was used for
further analysis due to additional information of stroke
severity. Crude odds ratios (ORs) with 95% conﬁdence
intervals (95% CIs) and ORs adjusted for potential
confounders were calculated. A two-sided P value
<0.05 was considered statistically signiﬁcant. Statistical
analysis was performed with the Statistical Package for
the Social Sciences, SPSS (SPSS Inc., 23.0 for Win-
dows, IBM, Armonk, NY, USA).
Ethics
The CADISP study protocol (http://clinicaltrials.gov/
ct2/show/NCT00657969) was approved by competent
local authorities of all participating centres and is con-
ducted according to the national rules concerning
ethics committee approval and informed consent.
Results
In all, 778 CeAD patients with documented informa-
tion about PT, NIHSS and mRS at 3 months com-
prised the ﬁnal study sample. 63 patients (8.1%)
reported PT (PT+ patients), 29 of 311 (9.3%) prospec-
tively enrolled patients and 34 of 467 (7.3%) retro-
spectively enrolled patients (P = 0.348). PT+ patients
were more likely to be female (65.1% vs. 41.6%,
P < 0.001) and were less likely to present with ischae-
mic stroke (41.3% vs. 63.9%, P = 0.001). Amongst
the PT+ patients, 54 (77.8%) had dissections in the
internal carotid artery, compared to 459 (60.6%) of
the PT patients (P = 0.001). Moreover, ﬁve patients
(7.9%) in the PT+ group and 26 patients (3.6%) in
the PT group had dissections in both internal caro-
tid artery and vertebral artery. Thus the total propor-
tions of internal carotid artery dissection were 85.7%
and 64.2% (P = 0.001), respectively. Occlusion was
less frequent in PT+ patients than in PT patients
(19.0% vs. 34.1%, P = 0.017). Median mRS after
3 months was 0 in PT+ patients versus 1 in PT
patients (P = 0.016). Excellent outcome after
3 months favoured PT (92.1% vs. 75.4%, P = 0.002).
The rate of recurrent stroke was low and not diﬀerent
between the PT and PT+ groups [15 (2.1%) vs. 0,
P = 0.627] (Table 1).
Logistic regression analysis identiﬁed PT as a pre-
dictor for excellent outcome after 3 months (OR 3.96,
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95% CI 1.22–12.87). The association between PT and
outcome was independent from other signiﬁcant out-
come predictors such as NIHSS on admission (OR
0.82, 95% CI 0.79–0.86), Horner syndrome (OR 1.95,
95% CI 1.16–3.29) and vessel occlusion (OR 0.62,
95% CI 0.40–0.94) and from non-signiﬁcant predic-
tors such as age (OR 0.98, 95% CI 0.96–1.00), male
sex (OR 1.45, 95% CI 0.94–2.24), pain (OR 0.91,
95% CI 0.53–1.55) and location of CeAD (Table 2).
Discussion
In this study PT was associated with a favourable out-
come in patients with CeAD. PT+ patients had an
almost four-fold increased likelihood of an excellent
outcome compared to those without PT. Presence of
PT was also associated with female sex, lower
likelihood of stroke, fewer arterial occlusions and
fewer dissections in the vertebral artery. Logistic
regression analysis showed PT to be an independent
predictor for excellent outcome adjusted for age, sex,
NIHSS, Horner syndrome, pain, vessel occlusion and
location of CeAD.
In this study the focus was on easily assessable clin-
ical parameters (age, sex, NIHSS, Horner syndrome,
pain and PT) to allow the treating physician to gain a
quick overview of patients‘ characteristics which might
be associated with more benign course. As recently
reported for Horner syndrome, PT is associated with
a more benign clinical course of CeAD [13]. Our
study did not attempt to discover the mechanism
behind PT in CeAD but rather described the authentic
clinical situation in these patients.
Although PT is less frequently reported than other
local signs such as pain or Horner syndrome, it was
not rare, being reported by 8.1% of our patients.
Because PT predicts favourable outcome, it should be
of interest and physicians should speciﬁcally ask for
its presence. The underlying cause of a newly occurred
PT is in up to 20% cervical artery stenosis or aneur-
ysm [8,14]. Thus a newly occurred PT should lead
clinical and vascular examination to exclude underly-
ing CeAD. PT was the only clinical sign of CeAD in
three of our patients. In addition, a newly occurred
PT in the course of CeAD might indicate changes in
vessel status like revascularization of an occlusion or
vice versa. In our analysis PT predicted favourable
outcome independent of vessel occlusion. This might
be surprising because PT is supposed to be related to
vessel status, especially to high grade stenosis. One
Table 1 Patients‘ characteristics and outcome according to pulsatile tinnitus (PT)
No PT (n = 715) PT (n = 63) P
Age, mean (SD) 44.2 (10.2) 44.8 (9.3) 0.66a
Female sex 296 (41.6%) 41 (65.1%) <0.001b
Stroke 457 (63.9%) 26 (41.3%) 0.001b
TIA 164 (22.9%) 17 (27.0%) 0.441b
NIHSS on admission, median (range) 2 (0–25) 1 (0–18) 0.275c
Purely local symptoms (no ischaemia) 148 (20.7%) 27 (42.9%) <0.001b
Pain (neck pain/headache) 579 (81.0%) 53 (84.1%) 0.616b
Horner syndrome 206 (28.8%) 24 (38.1%) 0.149b
ICAD 433 (60.6%) 49 (77.8%) 0.001b
VAD 256 (35.8%) 9 (14.3%)
ICAD+VAD 26 (3.6%) 5 (7.9%)
Occlusion 244 (34.1%) 12 (19.0%) 0.017b
PT as the only symptom n.a. 3 (4.8)
mRS 3 months, median (range) 1 (0–5) 0 (0–3) 0.016c
Excellent outcome (mRS 0–1) 539 (75.4%) 58 (92.1%) 0.002b
Recurrent stroke 15 (2.1%) 0 0.627
ICAD, internal carotid artery dissection; mRS, modiﬁed Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; TIA, transient
ischaemic attack; VAD, vertebral artery dissection. The analysis of NIHSS on admission was restricted to the subgroup of patients with
ischaemia. aStudent’s t test; bFisher’s exact test; cMannWhitney U test.
Table 2 Logistic regression analysis with excellent outcome (mRS
0–1) as dependent variable
OR 95% CI P
Age 0.98 0.96–1.00 0.065
Male sex 1.45 0.94–2.24 0.115
NIHSS on admission 0.82 0.79–0.86 <0.001
Pulsatile tinnitus 3.96 1.22–12.87 0.026
Horner syndrome 1.95 1.16–3.29 0.012
Pain (neck pain/headache) 0.91 0.53–1.55 0.722
Occlusion 0.62 0.40–0.94 0.025
Location (ICA vs. VA)a 1.03 0.65–1.62 0.957
CI, conﬁdence interval; NIHSS, National Institutes of Health Stroke
Scale; OR odds ratio. Location site of dissection: ICA, internal caro-
tid artery; VA, vertebral artery. aPatients with CeAD in both ICAD
and VAD are not included in the regression analysis.
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could therefore speculate that PT might be a surrogate
of non-occlusion of the aﬀected vessel and this fact
drives the association of PT and favourable outcome.
But this could not be excluded or conﬁrmed by our
data. It is not known in how many tinnitus patients
the vessel status (occlusion/stenosis of various degrees)
was the same (i) at the time of vascular imaging and
(ii) at the time of occurrence of tinnitus; the time
course of PT was not recorded. Thus for example late
occurrence or disappearance in the course of PT could
not be analysed. This is the main limitation of our
study. The prognostic signiﬁcance of PT is not yet
understood and the interpretation remains speculative.
Another major limitation of our study is the lack of
information about the degree and the detailed location
(i.e. arterial segment) of the stenosis. Comparing ret-
rospectively and prospectively included CeAD patients
PT reporting was within the same range of 7%–9%.
This might indicate that selection bias in reporting PT
is not crucial. However, under-reporting of PT in
severely aﬀected patients cannot be excluded.
Conclusion
The presence of PT in CeAD is associated with a
benign clinical course with lower probability of stroke,
less severe strokes and better outcome at 3 months.
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